[VIRTUAL] Three-year outcomes from the European registry safety study (iriss): long-term observational data from patients with DME treated with the 0.19 mg fluocinolone acetonide (FAc; iluvien) intravitreal implant in clinical practice

Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma

R. Khoramnia; F. Koch; U. Chakravarthy; S. Taylor; J. Castro de Sousa; C. Bailey

Sep 28, 2020